Clinical trial / 2011
Flaxseed powder supplementation was linked to improved glycemic and lipid markers in diabetics
In an open-label non-randomized study of 29 adults with type 2 diabetes, 18 subjects chose daily supplementation with 10 g flaxseed powder for one month while 11 received no intervention. Flaxseed supplementation was linked to reductions in fasting blood glucose by 19.7% and glycated hemoglobin by 15.6%. Total cholesterol decreased by 14.3%, triglycerides by 17.5%, and low-density lipoprotein cholesterol by 21.8%, while high-density lipoprotein cholesterol rose by 11.9%.
- Study type
- Non-randomized open-label controlled trial
- Who was studied
- 29 adults with type 2 diabetes
- What was measured
- Glycemic and lipid parameters
THE PAPER
An open-label study on the effect of flax seed powder (Linum usitatissimum) supplementation in the management of diabetes mellitus.
Mani UV, Mani I, Biswas M, Kumar SN. J Diet Suppl, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.